Benoı̂t Viollet
Impact in
- Geriatrics and Gerontology top 0.02%
- Sirtuins and Resveratrol in Medicine
- Physiology top 0.05%
- Adipose Tissue and Metabolism
Papers in
-
- Metabolism, Diabetes, and Cancer 244
- PI3K/AKT/mTOR signaling in cancer 20
- Surgery 156
- Pancreatic function and diabetes 150
- Co-authors
- Marc Foretz (145 shared papers)Mondira Kundu (2 shared papers)Joungmok Kim (1 shared paper)Kun‐Liang Guan (1 shared paper)Bruno Guigas (22 shared papers)Fabrizio Andréelli (23 shared papers)Jocelyne Leclerc (19 shared papers)Luc Bertrand (18 shared papers)
- Journals
- Journal of Biological Chemistry (26 papers)Diabetes (23 papers)PLoS ONE (14 papers)Cell Metabolism (12 papers)The FASEB Journal (10 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Benoı̂t Viollet
342 papers receiving 43.4k citations
Benoı̂t Viollet's Hit Papers
Peers
Comparison fields: 5 of 166
- Geriatrics and Gerontology 2.2k
- Physiology 2.1k
- Aging 697
- Molecular Biology 25.9k
- Physiology 8.7k
Countries citing papers authored by Benoı̂t Viollet
This map shows the geographic impact of Benoı̂t Viollet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t Viollet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t Viollet more than expected).
Fields of papers citing papers by Benoı̂t Viollet
This network shows the impact of papers produced by Benoı̂t Viollet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t Viollet. The network helps show where Benoı̂t Viollet may publish in the future.
Co-authors
The 25 scholars most cited alongside Benoı̂t Viollet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 347 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Hit paper breakdown → | 2011 | 5849 |
| 2 | Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy Hit paper breakdown → | 2010 | 2142 |
| 3 | Cellular and molecular mechanisms of metformin: an overview Hit paper breakdown → | 2011 | 1425 |
| 4 | Metformin: From Mechanisms of Action to Therapies Hit paper breakdown → | 2014 | 1149 |
| 5 | Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state Hit paper breakdown → | 2010 | 984 |
| 6 | Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth Hit paper breakdown → | 2007 | 771 |
| 7 | AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo Hit paper breakdown → | 2012 | 749 |
| 8 | Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner Hit paper breakdown → | 2010 | 745 |
| 9 | Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Hit paper breakdown → | 2013 | 691 |
| 10 | AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol Hit paper breakdown → | 2009 | 573 |
| 11 | Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status Hit paper breakdown → | 2016 | 534 |
| 12 | The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo Hit paper breakdown → | 2015 | 514 |
| 13 | Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus Hit paper breakdown → | 2019 | 484 |
| 14 | 2004 | 478 | |
| 15 | 2004 | 464 | |
| 16 | 2006 | 454 | |
| 17 | 2007 | 433 | |
| 18 | 2003 | 432 | |
| 19 | Metformin: update on mechanisms of action and repurposing potential Hit paper breakdown → | 2023 | 415 |
| 20 | 2009 | 410 |
About Benoı̂t Viollet
Benoı̂t Viollet is a scholar working on Molecular Biology, Surgery, Physiology, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 347 papers that have together received 43.9k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (244 papers), Pancreatic function and diabetes (150 papers), Adipose Tissue and Metabolism (48 papers), Autophagy in Disease and Therapy (32 papers), Cancer, Hypoxia, and Metabolism (27 papers), Diabetes Treatment and Management (25 papers), PI3K/AKT/mTOR signaling in cancer (20 papers) and Calcium signaling and nucleotide metabolism (14 papers). The work is most often cited by research in Geriatrics and Gerontology (2.2k citations), Physiology (2.1k citations), Aging (697 citations), Molecular Biology (25.9k citations) and Physiology (8.7k citations). Benoı̂t Viollet has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marc Foretz, Mondira Kundu, Joungmok Kim, Kun‐Liang Guan, Bruno Guigas, Fabrizio Andréelli, Jocelyne Leclerc, Luc Bertrand, Kei Sakamoto and Jørgen F. P. Wojtaszewski. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, PLoS ONE, Cell Metabolism and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.